Fact CheckerSign in

NCT06312917Completed

Effect of Physical Activity Intervention on Overweight and Obese Patients With Endometrial Cancer

Effects of Physical Activity Based on the Transtheoretical Model on Patients With Endometrial Cancer Undergoing Fertility-sparing Treatment: a Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 24 Apr 2025

Brief summary (registry, in English)

This study evaluated the clinical outcome of exercise management on patients with endometrial cancer treated with fertility preservation, including the effect of complete response rate, complete response time, recurrence rate, recurrence time, etc., and physical composition, to evaluate the effectiveness of physical activity on weight management.

Status (registry)
Completed
Study type
Interventional
Enrollment
72 (actual)
First submitted
25 Feb 2024
Start date
1 Aug 2023
Primary completion date
30 Dec 2023
Lead sponsor
Peking University People's Hospital
NCT number
NCT06312917

What you commit to

  • Study type: Interventional
  • Participants enrolled: 72
  • From 1 Aug 2023 to the primary completion date, 30 Dec 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Recurrent or metastatic disease; Currently participating in regular exercise at least 2 days per week; Pregnant at the start of the study; Or unwilling to comply with research requirements. Patients also completed the Physical Activity Readiness Questionnaire (PAR-Q) through a telephone interview. Patients with one or more potential exercise-related safety risks were excluded.

Who the study is looking for

  • Participants were patients who met the following predefined eligibility criteria: Ages 20-40; Overweight or obese; The pathological diagnosis was EC (endometrioid, grade I, no myometrium invasion or metastasis). Not pregnant; Be willing to comply with test requirements after being fully informed of all risks and inconveniences associated with the test.

Age in the registry: 20 years to 40 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Peking University People's Hospital
Coordinator of this site? Confirm its status
BeijingChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.